TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
Technology developed by the Pentagon’s controversial research branch is getting a huge boost amid the current coronavirus crisis, with little attention going to the agency’s ulterior motives for developing said technologies, their potential for weaponization or their unintended consequences. In January, well before the coronavirus (Covid-19) crisis would result in lockdowns, quarantines and economic devastation Read More…
Trump’s recent tweet to “shoot down and destroy any and all Iranian gunboats if they harass our ships” has sparked concern over a new war in the Middle East. However, the more immediate effect of Trump’s tweet has been a big boost in oil prices and a rise in the stock market. Was that Trump’s Read More…
Podcast: Play in new window | Download | EmbedSubscribe: Apple Podcasts | Email | RSSWelcome to The Daily Wrap Up, a concise show dedicated to bringing you the most relevant independent news, as we see it, from the last 24 hours (4/14/19). As always, take the information discussed in the video below and research it Read More…
Podcast: Play in new window | Download | EmbedSubscribe: Apple Podcasts | Email | RSSWelcome to The Daily Wrap Up, a concise show dedicated to bringing you the most relevant independent news, as we see it, from the last 24 hours (4/14/19). As always, take the information discussed in the video below and research it Read More…
President Trump has claimed that the U.S. no longer needs foreign oil and is “energy independent.” Yet, now the U.S. shale oil industry faces near total ruin, meaning that another “war for oil” could be in our future. With Trump again taking aim at Venezuela, we may be closer to war than we think. On Read More…
One of the most politically-connected yet scandal ridden vaccine companies in the United States, with troubling ties to the 2001 anthrax attacks and opioid crisis, is set to profit handsomely from the current Coronavirus crisis. In August 2001, biopharmaceutical company BioPort faced imminent disaster. A series of company scandals, controversial federal bail-outs and severe, adverse Read More…